UK markets open in 4 hours 5 minutes
NIKKEI 225
38,236.07 -37.98 (-0.10%) HANG SENG
18,420.36 +213.23 (+1.17%) CRUDE OIL
79.08 +0.13 (+0.16%) GOLD FUTURES
2,309.50 -0.10 (-0.00%) DOW
38,225.66 +322.37 (+0.85%) Bitcoin GBP
47,465.06 +1,706.85 (+3.73%)
Sarepta Therapeutics, Inc. (SRPT)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 130.90 |
| Open | 140.00 |
| Bid | 130.45 x 100 |
| Ask | 130.65 x 100 |
| Day's range | 130.05 - 142.79 |
| 52-week range | 55.25 - 159.89 |
| Volume | |
| Avg. volume | 854,621 |
| Market cap | 12.348B |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | 303.79 |
| EPS (TTM) | 0.43 |
| Earnings date | 31 Jul 2024 - 05 Aug 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 166.05 |
ZacksSarepta (SRPT) Q1 Earnings Beat Estimates, Revenues Up Y/Y
Sarepta (SRPT) reports better-than-expected Q1 earnings on the back of strong sales for recently-approved DMD gene therapy Elevidys.
Insider MonkeySarepta Therapeutics, Inc. (NASDAQ:SRPT) Q1 2024 Earnings Call Transcript
Sarepta Therapeutics, Inc. (NASDAQ:SRPT) Q1 2024 Earnings Call Transcript May 1, 2024 Sarepta Therapeutics, Inc. beats earnings expectations. Reported EPS is $0.37, expectations were $-0.11. Sarepta Therapeutics, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good afternoon and welcome […]
- Thomson Reuters StreetEvents
Q1 2024 Sarepta Therapeutics Inc Earnings Call
Q1 2024 Sarepta Therapeutics Inc Earnings Call
© 2024 Yahoo. All rights reserved.